P H Smith
About
In The Last Decade
P H Smith
5 papers receiving 73 citations
Peers
Comparison fields: 5 of 23
- Molecular Biology 69
- Cell Biology 23
- Pulmonary and Respiratory Medicine 18
- Cancer Research 16
- Immunology and Allergy 9
Countries citing papers authored by P H Smith
This map shows the geographic impact of P H Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P H Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P H Smith more than expected).
Fields of papers citing papers by P H Smith
This network shows the impact of papers produced by P H Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P H Smith. The network helps show where P H Smith may publish in the future.
Co-authorship network of co-authors of P H Smith
This figure shows the co-authorship network connecting the top 25 collaborators of P H Smith. A scholar is included among the top collaborators of P H Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P H Smith. P H Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | A pharmacological comparison of gefitinib (IRESSA) and erlotinib | 2 |
| 3 | 67 | |
| 4 | Prognostic factor analysis from EORTC trials in advanced prostatic cancer. EORTC-GU Group. | 2 |
| 5 | EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group. | 2 |
| 6 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.